Determination of plasma metformin by a new cation-exchange HPLC technique. (Record no. 10324188)

MARC details
000 -LEADER
fixed length control field 01402 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513184212.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199908s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0163-4356
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/00007691-199906000-00015
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Bonfigli, A R
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19990803
245 00 - TITLE STATEMENT
Title Determination of plasma metformin by a new cation-exchange HPLC technique.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Therapeutic drug monitoring
Date of publication, distribution, etc. Jun 1999
300 ## - PHYSICAL DESCRIPTION
Extent 330-4 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Oral
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chromatography, High Pressure Liquid
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chromatography, Ion Exchange
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetes Mellitus, Type 2
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hypoglycemic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Metformin
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Reproducibility of Results
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sensitivity and Specificity
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Manfrini, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gregorio, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Testa, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Testa, I
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name De Sio, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Coppa, G
773 0# - HOST ITEM ENTRY
Title Therapeutic drug monitoring
Related parts vol. 21
-- no. 3
-- p. 330-4
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/00007691-199906000-00015">https://doi.org/10.1097/00007691-199906000-00015</a>
Public note Available from publisher's website

No items available.